Clinical efficacy of hepatic arterial infusion chemotherapy combined with transhepatic arterial embolization plus lenvatinib and tislelizumab or transarterial chemoembolization combined with lenvatinib plus tislelizumab in the treatment of advanced hepatocellular carcinoma

PurposeAdvanced hepatocellular carcinoma (HCC) remains a challenge for clinical treatment. The purpose of this study is to compare the efficacy of a quadruple combination of hepatic arterial infusion chemotherapy (HAIC) with transhepatic arterial embolization (TAE), lenvatinib, and tislelizumab (THL...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Zha Peng, Yaqiong Wang, Boyu Chen, Zhuangrong Zhu, Chengyi He, Yang Wei, Hai Huang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-12-01
Sarja:	Frontiers in Oncology
Aiheet:	hepatocellular carcinoma transhepatic arterial embolization hepatic arterial infusion chemotherapy transarterial chemoembolization lenvatinib tislelizumab
Linkit:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1665348/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!